Investor News

Home>News>Investor News

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

https://www.eurekalert.org/pub_releases/2018-12/uoc–nci120418.php

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs

UNIVERSITY OF CALIFORNIA – SAN DIEGO

Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […]

2018-12-20T02:44:33+11:00December 20th, 2018|

‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

Sydney Morning Herald (By Esther Han)

19 December 2018 — 12:00am

https://www.smh.com.au/national/revolutionary-cancer-drug-using-genetically-modified-cells-approved-20181217-p50msk.html

A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.

Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […]

2018-12-20T00:05:33+11:00December 19th, 2018|

The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System

An interview with UK immunologist Daniel Davis on national Public Radio’s “Fresh Air” is a good discussion about his new book for a general audience.

https://www.npr.org/2018/11/26/670793745/the-beautiful-cure-reveals-the-profound-power-of-the-immune-system

November 26, 20181:51 PM ET Heard on Fresh Air

Immunologist Daniel Davis says scientists are harnessing the power of the immune system to create new medications […]

2018-11-29T03:48:15+11:00November 29th, 2018|
Go to Top